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Introduction 
Abstract 	  
Mechanical ventilation has undergone tremendous change in its fifty years of 
mainstream usage.  In that time it has made the treatment of previously fatal 
diseases possible.  Importantly, research has shown that it also has the 
potential to cause or exacerbate disease.  This paper seeks to explore some 
of the more common complications of mechanical ventilation, and methods in 
which they may be prevented or ameliorated. 
Key Words 	  
Mechanical ventilation, weaning, ventilator-associated pneumonia, ventilator -
associated lung injury, positive end expiratory pressure, recruitment, post-
operative respiratory failure. 
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List of Abbreviations 	  
Abbreviation Meaning 
ALI acute lung injury 
APACHE acute physiology and chronic health evaluation II 
ARDS acute respiratory distress syndrome 
BAL broncho-alveolar lavage 
CDC centres for disease prevention and control 
ETCO2 end-tidal carbon dioxide 
FiO2 fraction of inspired oxygen 
ICU intensive care unit 
LA left atrium 
LV left ventricle 
PaO2 partial pressure of arterial oxygen 
PBW predicted body weight 
PEEP positive end expiratory pressure 
POPC post-operative pulmonary complications 
PRF post-operative respiratory failure 
RA right atrium 
RASS Richmond agitation and sedation scale 
RV right ventricle 
TIVA total intravenous anaesthesia 
TNF tumour necrosis factor 
V:Q ventilation to perfusion ratio 
VALI ventilator-associated lung injury 
VAP ventilator-associated pneumonia 
VILI ventilator-induced lung injury 
Vt tidal volume 
WOB work of breathing 
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Respiratory Physiology 
Normal Respiratory Function 
 
Breathing in humans is typically facilitated through two groups of muscles (1).  
The diaphragm lengthens the thorax during inspiration and shortens via 
elastic recoil during expiration.  The diaphragm is usually the only respiratory 
muscle playing a significant role during normal, quiet breathing. 
 
The second group of muscles are those that cause changes in thoracic 
dimensions.  The major muscles of thoracic excursion are the external 
intercostals, the sternocleidomastoid, the anterior serati, and the scaleni (2).  
During heavy, exertional breathing, the ribs are pulled caudally, expanding the 
thorax some twenty per cent.   Muscles that contract the thorax are the 
abdominus recti and the interior intercostals.  These muscles are active during 
times of heavy breathing.  Pathologies causing either an increase in 
abdominal pressure or dysfunction of abdominal musculature may interfere 
with breathing (3). 
 
The tracheobronchial tree consists of 23 generations (trachea = 0, alveoli = 
23), which are counted using the Weibel classification system (2, 3).  The 
number of passages roughly doubles with each generation so the number of 
passages can be mathematically expressed as 𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑝𝑎𝑠𝑠𝑎𝑔𝑒𝑠 =(𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛  𝑛𝑢𝑚𝑏𝑒𝑟)!. The mean diameter of the trachea is 1.8cm and is 
supported by U-shaped cartilaginous rings.  Posteriorly, the trachea joins the 
oesophagus via bands of smooth muscle.  This is of import because, despite 
the solid nature of the cartilaginous rings, it is possible to occlude the trachea 
if the intrathoracic pressure exceeds 50 – 70 cmH20. 
 
Small bronchi begin at approximately generation number 7 and have a 
diameter ranging from 3.5mm – 1mm.  Because smaller bronchi do not attach 
directly to the pulmonary parenchyma, they rely on a discontinuous network of 
cartilage to maintain patency, and on transmural pressure for airflow.  By the 
eleventh generation, the cartilage disappears from the airway wall (now ≤1mm 
in diameter) and the pulmonary parenchyma and the elastic recoil of the lung 
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instead hold the passages open (3).  The bronchioles also have a layer of 
helical smooth muscle under three types of control.  The sympathetic nervous 
system causes dilation of the bronchioles via ß adrenergic stimulation by 
nor/adrenaline.  Conversely, the parasympathetic nervous system via 
acetylcholine and the vagus nerve promote constriction.  Additionally, 
histamine exerts local control and leads to constriction as well. 
 
The average adult lung contains 130.000 primary lobules, with each lobule 
containing approximately 2000 alveoli in a diameter of 3.5mm.  From a 
functional standpoint, each primary lobule can be viewed as a large alveolus 
(3).  Ranging from 200 – 600 million, the average, healthy adult lung contains 
around 300 million alveoli.  The size of the alveoli is directly proportional to 
lung volume, except at the point of maximal inflation.  This size differential is 
exhibited in a vertical, gravity-dependant gradient, with the larger alveoli found 
at the apex of the lung.  At functional residual capacity, the mean alveolar 
diameter is 0.2mm (3). 
 
Gravity-dependence is seen to a greater degree in the pulmonary vasculature.  
The pulmonary vasculature carries the same flow as its systemic counterpart, 
however is does so at about 1/6 the pressure.  These lower pressure vessels 
are significantly thinner than their systemic counterparts, with the media being 
approximately half as thick (2, 3).  Pulmonary arterioles are mostly elastic and 
lack significant muscle.  At rest, approximately 75% of the pulmonary vascular 
bed is filled, creating a gravity-dependant V/Q ratios.  Inflation of the alveoli at 
higher (or lower) pressures will cause a change in vascular resistance, 
leading to redistribution of blood within the pulmonary system. 
 
The walls of the alveoli consist of a basement membrane sandwiched 
between 2 layers of pulmonary epithelium.  Within the walls are the pulmonary 
capillaries, elastin, collagen, and various immunologically active cells such as 
neutrophils and macrophages (4).  Intra-alveolar septa are fenestrated by 
pores of Kohn, allowing for movement of air and immunologic cells. In the 
area of gas exchange, the capillary and alveolar epithelia are closely 
opposed, sitting 0.4µm apart. 
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Pressure drives air movement in the respiratory system, and as such, a brief 
review of pressures and volumes is warranted. 
 
The alveolar pressure at rest, with unimpeded airways and an open glottis, is 
0cmH2O (or equal to atmospheric pressure). 
 
Plural pressure holds the alveoli open and in a normal, healthy lung sits at 
about -5cmH2O at the beginning of inspiration.  During inspiration, the plural 
pressure drops to -7.5cmH2O. 
 
Transpulmonary pressure is the difference between the alveolar and plural 
pressures.  It is also referred to as the recoil pressure. 
 
Compliance is used as a measure by which certain changes in ventilation are 
monitored, and is defined as the extent to which the lungs will expand per unit 
of increase in transpulmonary pressure.  There are two characteristics of 
compliance.  The first is the tissue-elastic forces tending towards the collapse 
of the air-filled lung.  The tissue-elastic forces account for approximately 1/3 of 
the total lung elasticity.  Alveolar fluid:air surface tension accounts for the 
remaining 2/3.  Importantly, if one were to measure the compliance of the 
entire lung-thorax system, it would be approximately half of the lungs alone.  
This means that the thorax contributes the same tendency to collapse the air-
filled lungs as do the lungs and pleura themselves (3, 4). 
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Figure 1 
 
 
 
Of particular note in this paper is the clinical ability to measure the various 
airway pressures.  Alveolar pressure is relatively simple to measure in a 
sedate patient who is breathing passively and is termed “plateau pressure”.  It 
Reproduced with permission from the New England Journal of Medicine. 
Intrathoracic Pressures and Lung Stretching. Panel A shows end inspiration in a patient with normal lung 
function who is breathing spontaneously (with an open glottis); the alveolar pressure (Palv) is 0, and the 
pleural pressure (Ppl) is negative (−8 cm of water), creating a transpulmonary pressure (Ptp) of +8 cm of water 
(Palv minus Ppl). Panel B shows the same lung while the patient undergoes general anesthesia and positive-
pressure ventilation with the use of the same tidal volume as in Panel A. The lung would be similarly 
stretched, with an alveolar pressure of 9 cm of water and a pleural pressure of 1 cm of water for a 
transpulmonary pressure of +8 cm of water. Panel C shows end inspiration in a patient with severe obesity, 
massive ascites, or pleural effusions, who may have a very stiff chest wall. In such patients, much of the 
pressure that is applied by the ventilator will be used to distend the chest wall rather than the lung. As such, the 
plateau pressure may be high, but so will the pleural pressure, and hence there may not be an increase in 
transpulmonary pressure with accompanying lung overdistention. Panel D shows a musician playing a 
trumpet, which can result in airway pressures of as much as 150 cm of water. However, because of the positive 
pleural pressure developed by the respiratory muscles, the pressure across the lung will not exceed normal 
values. Panel E shows a patient with marked dyspnea who is undergoing a type of mechanical ventilation that 
requires the active contraction of the respiratory muscles to initiate the assisted breath (e.g., noninvasive 
ventilation or pressure-support ventilation). In such cases, there may be large negative swings in pleural 
pressure, leading to a very high transpulmonary pressure, even though the airway pressure is only 10 cm of 
water. 
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represents the pressure required to distend the chest wall and lung together.  
Likewise, mean airway and peak inspiratory pressures are both easily 
obtained.  Unfortunately, if we are to calculate transpulmonary pressure, then 
measurement of pleural pressure is also required.  Currently, no method 
exists to directly measure this pressure in the clinical environment.  The only 
readily available surrogate is oesophageal pressure, which provides only a 
rough estimate as it is affected by the cardiac movement, the lungs, and by 
the oesophagus itself. (5) 
 
Normal Respiratory Immune Response 
 
Protection of the respiratory system actually begins at the nose where the air 
is warmed, humidified, and filtered via turbulent airflow and gravitational 
precipitation (2-4). 
 
In its entirety the respiratory system is coated in mucous (to varying degrees) 
secreted by goblet cells and sub-mucosal glands.  This mucous serves 
several purposes.  It keeps the surfactant moist, allowing for a continued 
decrease in surface tension.  Respiratory mucous also traps small particles 
before they reach the terminal airways. 
 
The particles trapped in the mucous are the removed to the pharynx by 
ciliated epithelium which beats approximately 10 – 20 times per second (3).  
The cilial beat has two phases, fast and slow.  The fast beats are always 
directed caudally and are responsible for moving particulate matter out of the 
airways.  Normally   a particle within the mucous layer will be moved a few 
millimetres every minute (2).  Upon reaching the pharynx, the particle-
containing mucous is either coughed or swallowed. 
 
Though comprising only 8% of pulmonary cells, the type I pneumocyte 
(epithelium) covers 95% of the alveolar surface area.  Importantly, these cells 
are able to take in particulate matter and then either facilitate movement of the 
particle away from the alveoli or undergo oxidative apoptosis.  Type I 
pneumocytes are not mitotically active. 
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Type II pneumocytes are best known for supplying surfactant to the alveoli via 
the release of osmophilic granules.  Surfactant reduces the alveolar surface 
tension and prevents collapse at lower pressures.  Type II cells are mitotically 
active and are able to replace damaged epithelium, eventually transforming 
into type I cells as required (2, 3). 
 
There are 3 types of macrophage commonly found within the respiratory 
system: airway, interstitial, and alveolar.  The three types share many 
commonalities and move between the three areas to varying degrees.  As a 
group they are derived from bone marrow, though – in the presence of bone 
marrow dysfunction, and in times of stress – they are able to undergo 
functional division for several generations (3).  All contain primary and 
secondary lysosomes.  All have surface receptors for IgG, IgM, C3, and 
various other opsonins.  All function as antigen-presenting cells for T cells.  
Finally, pulmonary macrophages produce mediators such as fibronectin, 
prostaglandins, leukotrienes, interferons, 
 and α1 anti-trypsin. 
 
	   10	  
Figure 2 
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Reproduced with permission from the New England Journal of Medicine.  
Lung Injury Caused by Forces Generated by Ventilation at Low and High Lung Volumes. 
When ventilation occurs at low lung volumes, lung in- jury can be caused by the opening and closing of lung 
units (atelectrauma) as well as by other mechanisms. This injury is magnified when there is increased lung 
inhomogeneity, as shown on computed tomography (Panel A), especially in patients with the acute respira- 
tory distress syndrome (ARDS) who have surfactant dysfunction, pulmonary edema, and atelectasis.11 In 
addition, ventilation may be very inhomogeneous, a status that may be partially or fully reversed by the use of 
positive end-expiratory pressure (PEEP), as shown in a ventilated ex vivo rat lung (see video in Slutsky and 
Hudson12). At high lung volumes, overdistention can lead to gross barotrauma (air leaks)13 (Panel B). Over- 
distention can also lead to increased alveolar–capillary permeability and gross pulmonary edema. Ventilation 
at both high and low lung volumes has structural, physiological, biologic, and systemic effects (Panel C). 
Mediators that are released into the lung can cause further lung injury, recruit neutrophils to the lung, or set the 
stage for the development of pulmonary fibro- sis. In addition, the increased alveolar–capillary permeability 
associated with ventilator-induced lung injury can lead to translocation of mediators, lipopolysaccharides, and 
bacteria into the systemic circulation, potentially leading to multiple-organ dysfunction and death. PaCO2 
denotes partial pressure of arterial carbon dioxide, PaO2 partial pressure of arterial oxygen, and PMN 
polymorphonuclear leukocytes. 	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The pulmonary lymphatic system has a capacity of approximately 500ml with 
the vessels lying mostly within potential spaces surrounding the vasculature 
and the various air passages.  Lymphatic flow from the left lung is to the 
thoracic duct, while the right lung drains to the lymphatic duct (2). 
Positive Pressure Ventilation 
 
History and Mechanisms of Positive Pressure Ventilation 
 
The idea of artificial ventilation is credited to Paracelsus, who used fire 
bellows connected to a tube inserted into the patient’s mouth.  In 1744 John 
Fathergill reported the first effective use of mouth-to-mouth resuscitation.  In 
1775 John Hunter devised a double-bellows system, a kind of a push-pull 
system designed to both introduce and draw out air.  In 1911 Dräger Medical 
produced what was probably the first commercially available, purpose built 
artificial respirator, called the Dräger Pulmoter; it was designed to be used by 
first responders.  The late 1800s and early 1900s also saw the development 
of negative pressure pulmonary ventilators, largely in response to polio.  Two 
main types reached common usage.  The first and most dramatic was the iron 
lung.  The patient was inserted, bodily, into a metal tube or box with his or her 
head left protruding.  The pressure in the device was reduced cyclically 
thereby drawing air in through the patient’s nose and or mouth.  The second 
type was known as the chest cuirass.  It was designed to enclose only the 
thorax and work on a similar principle to the iron lung.  It had the advantage of 
being significantly small and simpler, allowing many patients to remain at 
home. (6) 
 
Mechanical ventilation entered mainstream medicine as a result of its 
extensive use in the 1952 polio epidemic in Copenhagen, Denmark.  
Throughout the course of the epidemic, many principles were developed 
which have today become standard.  These include the use of cuffed 
endotracheal tubes, periodic sighs, and weaning.  It was also in this time 
period that the first mechanical positive-pressure ventilators were designed for 
long-term use.  During this time, the use of mechanical ventilation to support 
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patients with paralytic polio reduced the mortality rate from approximately 
80% to 40%. (7, 8) 
 
The 1960s gave rise to the era of respiratory intensive care with the 
production of the first proper volume-controlled and pressure-controlled 
ventilators.  While they are positively archaic by today’s standards, it is 
interesting to note the designers attempted to mimic normal breathing with 
sinusoidal waveforms, periodic sighs, and even PEEP to mimic pursed-lip 
breathing.  During the late 1960s and early 1970s, the first reports and 
conferences concerning what would later be termed ARDS began to appear. 
(6) 
 
The mid 1970s though the 1980s harkened the development of low-pressure 
endotracheal tubes to combat tracheal necrosis, permissive hypercapnoea, 
gas mixtures, high-frequency oscillatory ventilation, and high-frequency jet 
ventilation.  Various modes of ventilation, some still in use today, were also 
developed during this time.  These include pressure-support, pressure-
control, and interestingly inverse ratio ventilation. (6) The period covering the 
1980s until now has brought about not only derivative modes of ventilation, 
often focused on synchronisation, but more importantly an incredible amount 
of research.  Some, such as the ARDSnet studies, have forever changed the 
way we treat patients.  While others, such as the disappointing transition of 
high-frequency oscillatory ventilation to the adult population, have severed as 
a scientific head-scratch.  What has become clear is that mechanical 
ventilation can represent a potentially life-saving intervention, but that it also 
requires careful use and on-going, patient-specific tailoring. (6) 
 
Between forty and 60 per cent of ICU patients will require some sort 
mechanical ventilatory support.  This makes it only less common than the use 
of intravenous therapy, antibiotics, and – presumably – a bed.  From a 
different point-of-view, this represents about 3% to 4% of the hospitalised 
population. (9, 10) Unfortunately, there is no good European data available 
calculating the cost of mechanical ventilation.  However, in the US in 2005, 
mechanical ventilation represented approximately 12% of hospital costs at 
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around twenty-seven billion US dollars per year. (10) Whilst one must 
acknowledge that US healthcare costs are the highest in the world and that 
the increase in cost is likely not analogous to Europe, there is – regardless of 
location – an increase in labour intensity and complications regardless of 
location.  For the most part the increase in labour intensity occurs at the 
beginning of each patient’s mechanical ventilation.   
 
Advantage and reasons for Positive Pressure Ventilation 
 
Mechanical ventilation has essentially two main advantages.  Firstly, in the 
spontaneously breathing patient ,it allows us to reduce the work of breathing.  
Whilst this may sound trivial to some, work of breathing in a patient suffering 
from respiratory distress can represent up to forty per cent of the body’s 
energy and oxygen consumption.  Work of breathing is normally expressed in 
joules and is quite complex, (3) but in healthy individuals ranges from 0.3 – 
0.5 joules/L. (11) Normal determinants of work of breathing are essentially a 
sum of the inspiratory and expiratory forces to be overcome by the patient.  
 
Figure 3 
 
 
 
These include the chest wall elastance, lung elastance, transpulmonary 
pressure, resistive forces, and intrinsic PEEP.  This is best described using 
Campbell’s diagram in figure 2 below.  Obviously, when lung function is 
deranged, work of breathing increases significantly, mechanical ventilation 
Reproduced with permission from AnaestheisaUK 
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can reduce this work and allow the patient’s body to rest and redirect the 
oxygen and energy sources elsewhere. (3) Work of breathing is measurable 
in the clinical environment and research is underway to assess the utility of 
this in the prediction of success of weaning.  Unfortunately, due to the 
complexity of the research at these early stages, it is beyond the scope of this 
paper.  
 
Figure 4 
 
 
The second major advantage of mechanical ventilation is the ability to control 
pressure, volume, and gas mixtures in patients unable to do so themselves. 
(3) This includes patients in total respiratory failure, trauma patients, and 
patients undergoing surgery to name but a few. 
 
Cardiovascular Responses to Ventilation 
 
When considering the effects of mechanical ventilation on cardiac function, 
one must remember that mechanical ventilation functions in almost exactly 
the opposite manner as spontaneous respiration.  During positive pressure 
inspiration, air is forced into the lung at higher than atmospheric pressure, 
increasing the thoracic pressure.  The increase in thoracic pressure increases 
pressure in the right atrium (RA) and venous return as a whole, impeding 
1312
Fig. 1 Campbell’s diagram. Work of breathing measured by the
esophageal pressure: resistive WOB (Wresist), elastic WOB (Welast),
WOB related to active expiration (WOB expiratory) and WOB re-
lated to intrinsic PEEP (WPEEPi). Chest wall: this thick line (the chest
wall compliance) represents the pleural (esophageal) pressure ob-
tained when muscles are totally relaxed and lung volume increases
above functional residual capacity, measured in static conditions
The WOB is normally expressed in joules. One joule is
the energy needed to move 1 l of gas through a 10-cmH2O
s ure gradient. The work per liter of ventilation (J/l) is
the work per cycle divided by the tidal volume (expressed
in liters). I a healthy subject the n rmal value is around
0.35 J/l [7]. Lastly, WOB can be expressed in work per unit
of time, multiplying joules per cycle by the respiratory rate
(expressed in breaths per minute) to obtain the power of
breathing (joules/minute). In a healthy subject the normal
value is around 2.4 J/min [7]. As illustrated by the Camp-
bell diagram, two other phenomena affect the WOB: in-
trinsic PEEP (positive end-expiratory pressure, or PEEPi)
and active expiration.
PEEPi and active expiration
The distending pressure of the lungs is called the transpul-
monary pressure and it can be estimated as the difference
between airway and esophageal (pleural) pressure. At the
end of a normal expiration, alveolar and airway pressures
are zero relative to atmosphere, and esophageal pressure
is negative, reflecting the resting transpulmonary pressure
(around 5 cmH2O in normal conditions). However, in the
presence of PEEPi, the alveolar pressure remains positive
throughout expiration, because of either dynamic airway
collapse or inadequate time to exhale [8]. This implies that
some degree of dynamic hyperinflation does exist (lung
volume at end-expiration is higher than passive functional
residual capacity). Importantly, for lung volume to further
increase in a patient with PEEPi, the inspiratory muscles
contract to an amount equal to PEEPi before any volume
is displaced.
PEEPi can be quite high in patients with chronic
obstructive pulmonary disease (COPD) and may represent
a high proportion of the total WOB [9]. For example,
a patient who displaces 0.5 l of tidal volume through
a 7-cmH2O pressure gradient will perform an amount
of work of 0.35 J/cycle. If nothing else changes except
that this patient develops 5 cmH2O of PEEPi, 0.25 J
will be required to counterbalance this, meaning that the
total WOB will be 0.60 J (0.35 + 0.25), which represents
around 40% of the total work required for the inspiration.
The PEEPi value is measured as the drop in esophageal
pressure occurring during expiration when the inspiratory
muscles start contraction, until the flow reaches the point
of zero (see Fig. 1).
In the case of ineffective respiratory efforts, that is,
muscle contraction without volume displacement, WOB
cannot be measured from the Campbell diagram, since
this calculation is based on volume displacement. In
this situation, measurement of the pressure–time product
(PTP) may more accurately reflect the energy expenditure
of these muscles. The PTP is the product of the pressure
developed by the respiratory muscles multiplied by the
time of muscle contraction, expressed in cmH2O per
second. The relevant pressure is again the difference
between the measured esophageal pressure and the static
rel xation curve of the che t wall.
Expiration normally occurs passively. However, the co-
existence of PEEPi and active expiration is common, espe-
cially in COPD patients [10]. Positive expiratory swings
in gastric pressure are observed during active expiration as
a consequence of abdominal muscle recruitment. When the
patient starts contracting the inspiratory muscles, the expi-
ratory muscles also start to relax. The drop in esophageal
pressure used to estimate PEEPi is therefore also due to
the relaxation of the expiratory muscles. To avoid overesti-
mating the value of PEEPi, the abdominal pressure swing
resulting from the active expiration must thus be subtracted
from the initial drop in esophageal pressure [10].
Technical aspects of WOB calculation
Two other calculations can be obtained from pressure
and volume measurements: airway pressure WOB and
transpulmonary pressure WOB. The airway pressure
WOB displays the energy dissipated by the ventilator
to inflate the respiratory system. The transpulmonary
pressure WOB shows the energy needed to inflate the lung
parenchyma and reflects the mechanical characteristics
of the pulmonary tissue. The limitation of these two
measurements is that the amount of WOB performed by
the patient’s respiratory muscles is ignored.
The main tools used to measure the WOB are a double-
lumen polyethylene gastro-esophageal catheter–balloon
system and a pneumotachygraph. The catheter has an
esophageal and a gastric balloon, usually filled with
Reproduced with permission from Wiley Interscience.  
Campbell’s diagram. Work of breathing measured by the esophageal 
pressure: resistive WOB (Wresist), elastic WOB (Welast), WOB 
related to active expiration (WOB expiratory) and WOB related to 
intrinsic PEEP (WPEEPi ). Chest wall: this thick line (the chest wall 
compliance) represents the pleural (esophageal) pressure obtained 
when muscles are totally relaxed and lung volume increases above 
functional residual capacity, measured in static conditions 
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filling.  Increases in thoracic pressure are inversely proportional to right 
ventricular (RV) preload. (1, 12, 13).  In fact, one of the most common early 
complications of mechanical ventilation is the so-called “post-intubation 
cardiovascular collapse”.  Likely this is an unmasking of the patient’s fluid 
status as a result of decreased venous return, possible in combination with 
increased pulmonary vascular resistance and impaired RV function.  This can 
be largely offset by fluid challenge or appropriately, careful monitoring and 
fluid maintenance.  
 
RV function is also affected by lung volume.  At hyper-inflated lung volumes, 
lung volume may raise pressure on the pulmonary vessels enough to produce 
an increase in pulmonary vascular resistance.  Likewise, a decrease in lung 
volume can result in an increase in pulmonary vascular resistance through 
two mechanisms.  First, in ateletic areas of the lung, the pulmonary 
vasculature becomes tortuous and tends towards collapse.  Secondly, in both 
ateletic and poorly ventilated areas hypoxic vasoconstriction appears.  Any of 
these mechanisms either alone or, more likely in combination, have the 
potential to significantly increase pulmonary vascular resistance, 
consequently increasing RV afterload and inhibiting RV function. (1, 12, 13) 
Outside of these two extremes, the pulmonary vascular resistance tends to 
remain within physiologic norms.  There is, however, a small but significant 
rise in pulmonary arterial pressure. 
 
Interestingly, the left ventricle (LV) is differently affected than the right.  
Because the aorta lies within the pleura it is subject to plural pressures.  For 
this reason, the pressure increase during mechanical ventilation decreases 
LV afterload, actually increasing cardiac output in certain populations of 
patients.  Likewise the application of PEEP may be of cardiovascular benefit 
in patients suffering the effects of ventricular interdependence, such as those 
with a fluid overloaded RV or weak LV. (1, 12, 13) More often, however, the 
increase in RV afterload leads to a decrease in LV preload, leading to 
decrease LV output. 
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The use of PEEP, while beneficial from a pulmonary standpoint, prevents the 
thoracic pressure from ever returning to atmospheric.  This creates a situation 
in which, outside of the normal tidal pressure changes, intra-thoracic pressure 
remains elevated.  This leads to a sustained decrease in venous return, and 
impaired RV filling. (1, 12, 13) Further, the increase in intra-thoracic pressure 
stimulates baroreceptors and has the potential to blunt adrenergic reflexes 
that may be able, to some extent, to counter these effects.  This is 
compounded by the sedatives and analgesics that are often employed in 
mechanical ventilation. 
 
Though difficult to quantify, one can reasonably suspect that all of these 
effects are present to varying degrees in the majority of patients under-going 
mechanical ventilation.  With this in mind, it is incumbent upon the user to 
anticipate and ameliorate them.  At present, it is possible to measure, or at 
least estimate, all of the relevant pressures in the clinical environment.  
Oesophageal pressure in this setting is an acceptable substitute for intra-
thoracic pressure, because the numeric value in this case is less important 
than the trend.  The pressures of all four cardiac chambers are attainable via 
echocardiography, and via these one is able to estimate pulmonary 
pressures.  Of course, if estimation is not sufficient, pulmonary catheterisation 
is available. (3) Realistically, this may trumpet the era of specifically tailored 
ventilator settings in response to cardiovascular function.  While this is has 
been suggested, it has yet to undergo significant clinical research. 
 
Common Complications of Mechanical Ventilation 
 
Difficulty Weaning 
 
Weaning from mechanical ventilation is the process by which ventilatory 
support is gradually removed.  Typically this occurs after resolution of the 
pathology requiring mechanical ventilation.  Success is defined by the 
absence of ventilatory support forty-eight hours after extubation. (1) Weaning 
is dependant on respiratory drive, physical and functional nerve integrity, 
motor end plate integrity, intact respiratory structures, sufficient muscle 
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strength, and the load against which they work.  Failure of any component can 
lead to weaning failure. (14) Most commonly, failure is a result of inadequate 
or incomplete resolution of the original problem, but may also be a problem of 
new onset related or unrelated to mechanical ventilation.  In the second 
category, the most common problems are ventilator-associated pneumonia 
and ventilator-associated lung injury. (14) Weaning generally comprises about 
half of the patient’s time on mechanical ventilation and is without complication 
between 70% and 80% of the time.  (15)Regardless of the reason for failure, 
the result is an increase in morbidity and mortality, lengthened ICU stay, 
poorer general prognosis, and an increase in cost. (16) Data show that 
prolonged periods of mechanical ventilation are associated with a mortality 
increase of between twenty and forty per cent.  Further, in those that do 
survive, many require assistance with activities of daily living. (17) 
 
Immobility, prolonged mechanical ventilation, systemic infection and 
inflammation are all associated with skeletal muscle dysfunction in critically ill 
patients. (18) Ventilator-associated diaphragmatic dysfunction was first 
described in 2004 (19) and is a function of altered gene expression, deranged 
protein synthesis, oxidative stress, and proteolysis producing rapid atrophy of 
the diaphragm.  To a lesser degree, the ancillary respiratory muscles are also 
accepted.  Human studies have shown the onset of ventilator-induced 
diaphragmatic dysfunction can occur in a little as 2 – 6 hours, however some 
degree of dysfunction almost universally presents after forty-eight hours. (20) 
One study measured a decrease in diaphragmatic mass of 6% per day. (21) 
This is in agreement with animal studies. Additionally, a 2002 study (22) found 
that the incidence of ICU-associated paralysis was ≥ 25%. 
 
Risk factors for failure to wean include recent infection, cardiovascular 
dysfunction, electrolyte imbalance, psychological dysfunction, endocrine 
disorders, neuromuscular weakness, open tracheostomy and previous failure 
to wean. (14) Additionally, female sex, higher acuity, pre-existing diabetes, 
and hepatorenal impairment were also associated with poorer outcomes. (22) 
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Patients undergoing weaning are categorised as simple, difficult, or 
prolonged, based on the number of spontaneous breathing trials, the number 
of weaning failures, and the total “weaning time”. (14) Of interest, but not yet 
in clinical use, is diaphragmatic assessment prior to or during weaning.  One 
study found that diaphragmatic dysfunction as demonstrated by excursion of 
≤10mm visualised by M-mode ultrasound during SBT was associated difficulty 
weaning. (23) 
Ventilator-Associated Pneumonia 
 
Ventilator-associated pneumonia (VAP) is defined as pneumonia occurring in 
a patient undergoing invasive mechanical ventilation. (3) The normal definition 
suggests 48 – 72 hours of mechanical ventilation are required prior to 
diagnosis however some data suggests ventilator-association is possible 
earlier than this. (24, 25) VAP represents approximately 80% of hospital 
acquired infection (3) and is the most common device-associated infection. 
(26) Predictably VAP is also the most common nosocomial infection in 
ventilated patients, and, in fact, the ICU. (27) The incidence of VAP is variable 
but is thought to sit between 1 - 4 cases per 1000 ventilator-case days in 
medical patients, and up to 10 cases per 1000 ventilator-case days in surgical 
patients. (28, 29) In general, this equates to between 8% and 28% of ICU 
patients. 
 
Despite the relatively clear incidence of VAP the mortality of the disease 
remains somewhat elusive, with estimates ranging from 0% - 60%. (30) It has 
been suggested that estimation of mortality in VAP is hampered by numerous 
confounding variables in a heterogeneous patient population.  Whilst 
multistate and competing risk models account for temporal variances, they are 
unable to overcome multiple confounding factors.  A recent meta-analysis (31) 
assessed data from 58 randomised prevention studies and concluded that the 
overall attributable mortality for VAP was 9%.  Though this may be accurate, it 
fails to take into account the complexity of the patient populations that 
contract VAP.  The same authors then conducted a second review in which 
they grouped patients by severity. (30) In this study they concluded that the 
overall mortality for VAP was 13%.  More interestingly, they noted that VAP 
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had no statistically significant impact in either trauma or medical patients with 
low (APACHE score <20 or SAPS <35) or high (APACHE >30 or SAPS >58) 
severity scores.  Patients with medium severity of illness scores were most 
affect by VAP, with medical patients faring better than surgical.  The authors 
feel that the increased risk of death in VAP could then actually be attributed to 
risks associated with longer ICU stays, rather than to VAP itself.  This 
conclusion seems reasonable, especially when one considers that the finding 
are consistent with Schumacher et al. (32) and Nguile-Makao et al. (33)  VAP 
does clearly increase the length of ICU stay, the duration of ventilation, and 
cost of care. (27, 28)  
 
As with all bacterial pneumonia, VAP occurs when bacteria enter the normally 
sterile lower respiratory tract and subsequently overcome the host-defence 
system, (28, 34) a system that is often weekend in ICU patients.  The Centres 
for Disease Control and Prevention (CDC) proposes three mechanisms by 
which colonisation occurs: aspiration of secretions, colonisation of the aero-
digestive tract, and contaminated equipment. (35) Aspiration, probably more 
commonly microaspiration, from the oropharynx is thought to be the dominant 
route of entry. (36) Colonisation is often found in the first week of hospital 
admission in critically ill patients. (3) On top of the complications often seen 
with pneumonia, VAP has the added complications that it is difficult to 
diagnose and often exhibits multiple drug-resistance.  The most commonly 
isolated causative pathogens in VAP are acinetobacter spp., P. aeruginosa, 
and S. aureus, though there is no statistically significant difference in clinical 
outcomes when the organism is considered. 
 
Some factors associated with VAP (other than intubation itself) are 
nasogastric tubes, re-intubation, aspiration, supine positioning, pooling of sub-
glottic secretions, coma, and enteral nutrition. (37, 38) 
 
Considering the difficulties that VAP presents, the most logical solution is 
prevention rather than treatment.  The primary method of prevention is to 
minimise intubation frequency and duration of ventilation. (3) To this end the 
CDC released the recommendations found in table 1 for the prevention of 
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VAP. (39) Though the exact impact of VAP on patients remains somewhat 
unclear, it has been shown to negatively affect mortality and morbidity, 
prolong ICU stays, increase the duration of mechanical ventilation, and 
increase associated costs. 
 
Table 1 - CDC VAP prevention guidleines 
i. Conduct VAP surveillance 
ii. Adhere to hand-hygiene procedures 
iii. Minimise invasive mechanical ventilation 
iv. Minimise the duration of ventilation  
v. Conduct daily assessments for readiness to wean 
vi. Conduct VAP education  
vii. Maintain head-of-bed (HOB) angle between 30° - 45° whenever 
possible 
viii. Avoid gastric overdistension 
ix. Avoid unplanned extubation and re-intubation 
x. Use a cuffed ETT with in-line or subglottic suction 
xi. Maintain a cuff pressure of at least 25cm H2O 
xii. Employ orotracheal intubation (vs. nosotracheal) whenever possible  
xiii. Avoid the use of H2 receptor-blockers and PPIs when possible 
xiv. Perform regular oral care 
xv. Remove condensate from the breathing circuit whilst it remains closed 
xvi. Change or replace the breathing circuit only when it is malfunctioning 
or visibly contaminated 
 
Ventilator-Associated/Induced Lung Injury (VALI/VILI) 
 
The concept of lung injury as a result of mechanical ventilation is not a new 
one.  The term “ventilator lung” first appeared in 1967 and described the post-
mortem findings of diffuse alveolar infiltrates and hyaline membrane formation 
in patients who had been mechanically ventilated. (5) Deaths often occurred 
despite normalisation of arterial blood gasses, and have been attributed to 
barotrauma, oxygen toxicity, and haemodynamic comprise induced by 
mechanical ventilation. (40) Today ventilator-induced lung injury and the 
clinical counterpart, ventilator-associated lung injury, are understood to 
involve inflammatory cell infiltrates, hyaline membranes, increased vascular 
permeability, and pulmonary oedema. (5) It is largely acknowledged that VILI 
is as complex and can be as damaging as the diseases supported by 
ventilation.  In fact, the pathology exhibited in VILI is almost identical to that 
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seen in acute lung injury (ALI) and acute respiratory distress syndrome 
(ARDS).  So much so that there is supporting the hypothesis that VILI may 
actually be capable of inducing both ALI/ARDS and its extra-pulmonary 
manifestation multiple organ failure (MOF). (35, 41)  VILI is a common 
complication in critically ill patients, contributing to increased mortality, 
morbidity, and length of stay. (5) Unfortunately, due to the variable nature of 
the disease, the exact incidence are unknown.  It is thought to affect 
approximately one-quarter of mechanically ventilated patients, though this 
number is almost certainly higher in those with pre-existing lung injury.  VILI 
appears to be induced via three major mechanisms: volutrauma, 
atelectrauma, and biotruama. 
Volutrauma 
 
In order to fully understand the concept of volutrauma, it is important to 
recognise that the lung represents a heterogeneous environment in which 
multiple pressures and pressure gradients exist at any given time, even in a 
healthy lung.  One must also comprehend that volume and pressure in the 
lung are part of the same concept.  With this is mind, it is easier to picture 
volutrauma as regional tissue overdistension, rather than a global increase in 
pressure. 
 
Wakabayashi et al. (42) used animal models to conclude that volutrauma 
caused a greater level of cytokine release compared to atelectrauma, and at 
least a comparable level of local tissue damage.  Post-experiment analysis 
showed that both volu- and atelectrauma caused significant increases in 
elastic resistance and lavage fluid protein levels, indicating capillary damage 
and pulmonary oedema.  It has been previously hypothesised that 
inflammatory mediators released from the lung in response to ventilator-
induced damage may be responsible for distant organ dysfunction. (43, 44) 
Possibly more important than the greater levels of pulmonary chemokines and 
tumour necrosis factor (TNF) the Wakabayashi study discovered, were the 
higher systemic levels.  The authors concluded the increased systemic levels 
of the inflammatory mediators were not explainable through overflow from the 
pulmonary system into systemic circulation, as has been postulated. Rather, 
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they believe it is representative of an extra-pulmonary source.  Predictably, 
high levels of lung-marginated leukocytes were also seen and may be 
responsible for secreting TNF into the circulation propagating further 
production.  This seems possible if one accepts that the lungs have the 
largest available pool of leukocytes in circulation.  Also lending credence to 
this theory is the finding that monocyte-depleted lungs exposed to similar 
stimulus did not induce such high levels of inflammatory mediators.  The 
monocyte-depleted lungs also showed less pulmonary oedema.  Further 
supporting the concept of volutrauma, another study showed that induced 
overdistension in spontaneously breathing animals produced lung injury 
consistent with high-volume mechanical ventilation. (45)  
 
Whilst atelectrauma produced elevated levels of inflammatory mediators it did 
so only in the alveolar compartment.  Both atelectrauma and volutrauma 
instigated similar levels of pulmonary oedema.  This last finding contradicts 
those of another study showing that high volume ventilation caused a greater 
level of pulmonary oedema than did high-pressure ventilation. (46) 
Atelectrauma 
 
Atelectasis refers to the collapse of the alveoli in response to alteration of 
regional pressure differences in the lung, surfactant dysfunction, splinting due 
to injury or other defect, residual effects of neuromuscular blockade or other 
muscular dysfunction, airway blockage, compression of the pulmonary 
structures, or high FiO2. (47) Central to this dysfunction is the alteration in the 
shape and function of the chest wall, whether caused pharmaceutically, 
physically, or surgically.  Abnormal thoracic wall motion contributes to 
negative regional V:Q alteration, bringing with it either an increase in dead 
space or pulmonary shunt. (41) Regardless of the cause, atelectasis is 
present in up to ninety per cent of intubated patients and is associated with a 
significant increase in post-operative pulmonary complications (41, 48). As 
atelectasis is often clinically silent, there is a paucity of data regarding the 
frequency at which it causes clinically adverse events.  Some data exists 
however demonstrating that up to 36% of patients with radiographically 
	   23	  
diagnosed atelectasis proceed to develop pneumonia in the post-operative 
setting. Atelectasis is also associated with an increase in alveolar bacterial 
growth. (49, 50)  
 
Figure 5 
 
 
 
Atelectrauma is thought to be caused by repetitive shear stress and direct 
inflammation caused by the repeated collapse and inflation of the alveoli in 
the presence of dysfunctional surfactant or other pathologies. (51) This 
concept may be thought of as tidal recruitment/derecruitment injury.  The 
healthy lung uses surfactant, alveolar interdependence, collateral ventilation, 
extracellular matrices, and the thorax to form an incredibly stable structure 
avoiding both collapse and over-inflation.  In general, a healthy lung will show 
only minimal changes in alveolar size or shape provided the total lung 
capacity remains between 10% - 80%. (51-53) Loss of any of these 
mechanisms creates instability and increases the risk of atelectrauma, and 
subsequently of VILI.  A disparate yet plausible theory is that small gas 
bubbles in non-aerated alveoli create large pressure fronts along the alveolar 
wall. (54) Such a gradient would cause large local pressure differences 
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macrophage recruitment and activation [77]. It was
postulated that this lung injury was independent of
the stresses caused by mechanical ventilation as it
can be reversed when increasing FiO2 and/or remov-
ing atelectasis by lung recruitment [25]. Future
studies are needed to determine the clinical signifi-
cance of any injury induced by atelectasis in patients
without previous pulmonary diseases. Whereas this
mechanism appears to be of little clinical import-
ance in anesthetized patients with previously
healthy lungs, in the context of a ‘multiple hit
theory’ (the cumulative effects of a series of less
intense insults contributing to injury), that atelec-
tasis may exert a synergistic or additive effect in
concert with other mechanisms known to contri-
bute to VILI [78,79].
Ventilator-induced lung injury
Fully developedVILI presents as bilateral pulmonary
infiltrates consistent with edema in the absence of
heart failure or severe, chronic lung disease [80].
Postoperatively VILI may present as acute lung
injury (ALI) or acute respiratory distress syndrome
(ARDS) [81,82&&,83]. The incidence of these entities
fluctuates depending on the population and
surgeries studied. For example, ALI has an incidence
between 2 and 6% in high-risk patients undergoing
thoracic surgeries [81,83–85]. Postoperative respir-
atory failure has estimated mortality that exceeds
45% in some populations [86,87]. Evidence is
accumulating that alveolar instability and atelecta-
sis may predispose to development of VILI [88,89].
Two main mechanisms are proposed: one is tidal
recruitment, the cyclic opening and closing of lung
units at the boundary between normally aerated and
collapsed tissue [90&]. During the respiratory cycle
these units are exposed to repetitive shear stress,
which ultimately destroys their cellular structures
(Fig. 2) [91]. The other mechanism is tidal over-
distension of nonatelectatic lung units. Atelectasis
causes the distribution of ventilation within the
lungs to become more heterogeneous shifting the
inspiratory flow preferentially to those parts of
the lungs that are already ‘open’. In this way alveoli
become functionally overinflated [92]. Tissue stress
is directly related to the size of tidal volume and
pressures applied by the mechanical ventilator.
On the basis of the lessons learned from
mechanical ventilation in patients with ALI/ARDS
[88,93,94], there is increasing evidence that sup-
ports the notion that the same mechanisms of
De-recruitment Overdistention
Pre-VILI Barotrauma
Volutrauma
Release of
inflammatory
cytokines
Biotrauma
IL-1β, IL-6, IL-8, TNFα
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inflammatory
cytokines
Low VT High VT, high PIP
No recruitmentNo PEEP
FIGURE 2. Ventilation of atelectatic areas can result in cyclic opening and closing of lung units (tidal recruitment), leading to
release of inflammatory cytokines causing atelectotrauma. High tidal volume and overexpansion of lungs can rupture alveolar-
capillary membranes (inset), leading to accumulation of neutrophils and release of inflammatory cytokines. IL, interleukin; TNF,
tumor necrosis factor; VILI, ventilator-induced lung injury. Adapted with permission from [91].
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amplifying the interaction of tissues and causing cellular injury. (55) Indirectly, 
atelectrauma also causes volutrauma via the preferential aeration and over-
inflation of the open areas lung as a derivative of the relative decrease in lung 
size from the loss of the non-aerated areas. (47) Additionally, and perhaps 
more simply, is the theory that the non-ventilated areas become hypoxic 
leading to cell death and the release of inflammatory mediators.  Given the 
evidence supporting multiple mechanisms of injury, it seems more likely that 
no one mechanism is responsible for the damage caused by atelectasis, and 
that instead multiple small insults accrue until such time as atelectrauma is 
manifest.  
Biotruama 
 
Related to the two above mechanisms, biotruama refers to the “translocation 
of mediators, bacteria, or lipopolysaccharide from the airspaces into the 
systemic circulation” (5) in cases of increased alveolar-capillary permeability 
as seen in ARDS, volutrauma, or epithelial microtears. This translocation may 
then propagate further pulmonary damage or distant organ dysfunction.  All 
epithelial, endothelial, and of course inflammatory cells in the pulmonary 
system are capable of participating in inflammatory reactions via various 
signalling pathways. (5, 42) Specifically IL-6, IL-8, and TNF have been 
implicated in pulmonary biotruama during clinical trials. (56) Mediator release 
can occur via two methods.  First, tissue trauma my cause cell death (or 
rupture) provoking the release of mediators. (57) Alternatively, lesser, non-
fatal injury to either the cytoskeleton or the extracellular matrix may cause 
inflammation via discrete intracellular signalling pathways. (58) 
 
Although volu-, bio-, and atelectrauma have been discussed separately, they 
must be considered, if not as different parts of the same entity, then as 3 
extremely interrelated entities. 
Complications and Effects of General Anaesthesia 
 
In general, one can predict several changes in patients under general 
anaesthesia.  Volatile agents impair mucous transport from the pulmonary 
tree, one of the respiratory systems primary protective measures.  Data 
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shows that sevoflurane significantly impairs ciliary beat frequency, thus 
decreasing bronchial mucous transport velocity (59).  The same impairment is 
not seen in patients undergoing total intravenous anaesthesia.  Likewise, 
almost all anaesthetic agents decrease respiratory drive and blunt respiratory 
reflexes.  
 
The use of inhaled volatile agents at any point is associated with a significant 
decrease in CD3+, CD4+ and, CD8+ T lymphocytes, NK cells, and B 
lymphocytes. Total intravenous anaesthesia is associated with a smaller 
decrease and more rapid return to normal. (60)  
 
All volatile anaesthetics, and in fact all intravenous anaesthetics save 
ketamine, cause a decrease in both systemic vascular resistance and mean 
arterial blood pressure.  This change in blood pressure seams almost entirely 
to occur via a decrease in systemic vascular resistance, as the cardiac index 
as measured by echocardiography is largely unchanged. (61) Still important 
but of little impact to this paper: some inhaled anaesthetics demonstrate a 
propensity towards dysrhythmogenicity and cardiac conduction disturbances, 
as well as a prolongation of the QT interval. 
 
All volatile anaesthetics increase the respiratory rate whilst decreasing the 
tidal volume in spontaneously breathing patients.  This produces a relatively 
preserved minute volume in the presence of increased dead-space 
ventilation.  In this setting, oxygenation is typically preserved, though often in 
the setting of increasing ETCO2. (***Millers) In healthy patients this may be as 
well tolerated as permissive hypercapnoea in any other ventilated setting.  It 
can however present possible consequences in the comorbid patient.  
Increased respiratory muscle activity seen during the use of inhaled 
anaesthetics also alters the chest wall dynamics. (***Millers) Inward 
displacement of the chest wall and cephalad displacement of the diaphragm 
produce a simultaneous increase in atelectasis and decrease in functional 
residual capacity.  While all inhaled anaesthetics have the potential to irritate 
the airways, this occurs almost exclusively during gas induction or at supra-
therapeutic concentrations.  Of interest, however, is that several inhaled 
	   26	  
anaesthetics are capable of bronchodilation.  This probably demonstrates a 
negligible effect in most patients, however it does have significant potential to 
benefit those with pulmonary comorbidities. (***Millers) 
 
Total intravenous anaesthetic (TIVA) procedures all, to one extent or another, 
produce a similar decrease in blood pressure, though most often in the 
presence of a decrease in heart rate. (***Millers) The two can be used in 
conjunction, termed mixed anaesthesia, in order to blunt the tachycardia seen 
in gas anaesthesia.  Contrary to volatile anaesthetics, TIVA generally inhibits 
respiratory drive.  If not supported, this leads to hypoxia and hypercarbia. 
 
Though not a general anaesthetic, spinal and epidural anaesthesia deserve 
some mention here.  Because the delivery of an anaesthetic to one specific 
level or dermatome is somewhat imprecise, this procedure sometimes 
produces hypotension and respiratory distress. (***Millers) The most 
dangerous potential side effect is termed total spinal anaesthesia.  It 
represents a total derangement of cardiovascular and respiratory control, and 
requires immediate, careful, and aggressive management. 
Strategies for the Prevention of Ventilator-Associated 
Complications 
 
Perioperative Prevention Strategies 
 
Perioperative complications are those conditions related to surgery arising 
within one month prior and three months after the procedure. Perioperative 
complications occur in 20% - 67% of elective surgeries, and more often in 
emergent surgeries. They account for 80% of surgery-related death and 
reduce median survival by up to 70%. (62-64) Post-operative pulmonary 
complications (POPC) occur at least as often as post-operative cardiac 
complications and contribute significantly to increased mortality and ICU 
admission. (65-68) POPC may be divided into acute, sub-acute, and delayed 
phases. 
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Residual neuromuscular blockade is associated with increased incidence of 
POPC. (66) This is explained via respiratory muscle weakness leading to 
hypoxia and respiratory failure.  Even in the absence of respiratory failure, 
residual blockade lengthens stays in the post-operative care unit. (47) It is 
advisable then to use appropriately timed neuromuscular blocking agents and 
ensure complete reversal through antagonistic agents prior to extubation as 
this has been shown to decrease POPC. (69) 
 
Figure 6 
 
 
 
Failure to wean from the ventilator after surgery may be due to retained 
anaesthetic or neuromuscular agents, but is more commonly associated with 
indirect lung injury resulting from the pathology at hand. (66) 
 
Aggressive fluid administration during the perioperative and operative periods 
is also associated with POPC. (66, 70) Every effort, therefore, should be 
made to avoid excess fluid whilst continuing to maintain an appropriate fluid 
balance. 
Smoking Cessation  
 
Ample data demonstrates that patients who smoke experience both an 
increased rate of surgical complications (71-75), and of perioperative death 
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
THE ROLE OF ATELECTASIS IN THE
PATHOGENESIS OF POSTOPERATIVE
PULMONARY COMPLICATIONS
The variable rates of PPCs reported are due to the
different types of complications studied, the clinical
criteria used in their definition, and the different
surgical populations reported [4,6]. The rate is
higher in older patients, in those with more comor-
bidities, and after complex operations. Up to 5.4%
high-risk patients may develop postoperative respir-
atory failure after elective operations, with the 27%
2-month mortality for those who developed acute
lung injury [40].
Intraoperative atelectasis is an important factor
in the pathogenesis of PPCs [4,41–43]. Atelectasis is
seldom visible on chest radiograms, but rather
requires chest computed tomography for detection,
so it is frequently underappreciated [4,14,36,44].
However, in many instances atelectasis itself does
not have clinical sequellae. Nonetheless, atelectasis
cannot be ignored because if it persists over time it
may become the starting point of a wide range of
other PPCs, not only limited to those in lungs
(Fig. 1), as further discussed.
Hypoxemia
Abnormalities of gas exchange in the perioperative
period range from a slight decrement in PaO2 to life-
threatening hypoxemia [45]. Atelectasis results in
V/Q mismatching due to either pulmonary shunt
or dead space [37]. Correlations exist between
pulmonary shunting and the amount of atelectasis,
and between areas of low V/Q and airway closure in
elderly [38,46,47]. Other causes of hypoxemia
include hypoventilation due to pain or residual
anesthetics, lung edema due to fluid overload,
exacerbation of chronic obstructive pulmonary
disease, laryngospasm or bronchospasm. However,
persistent postoperative hypoxemia in the absence
of other apparent causes should suggest the presence
of atelectasis [14,36,44]. The relief of hypoxemia by
treating lung collapse with noninvasive ventilation
supports a causative relationship. Use of continuous
positive airway pressure (CPAP) reduces the risk for
atelectasis [48], and noninvasive ventilation can be
used as a prophylactic and/or therapeutic tool to
improve gas exchange postoperatively [15]. Further-
more, the use of CPAP may decrease the rate of
reintubations and other complications after elective
surgeries [49].
Deleterious effects of atelectasis-related hypo-
xemia depend on the severity and duration of
hypoxemia, and on patient’s tolerance to hypoxia.
Several postoperative complications directly related
to hypoxemia have been identified:
(1) Hypoxemia-related deliriummay occur in up to
65% of postoperative patients [50,51] and
resolves with oxygen therapy [52].
(2) Wound infection is a potential consequence
of hypoxemia because the neutrophils’ ability
to kill bacteria depends on the surrounding
O2 tension [53–55]. A meta-analysis suggested
Anesthetic factors Surgical factors Patient factors
* Muscle dysfunction * Thoraco-abdominal surgeries * Age
* Muscle disruption * Surgical retractors * Body weight
* Low phrenic nerve output * Faulty surgical techniques * Smoking
* Pain * Pneumoperitoneum *Previous respiratory diseases
* Mucociliary dysfunction * Body positioning *Meteorism –abdominal
compartment syndrome.* Blood displacement between 
thorax and abdomen
* Fluid therapy
Respiratory restrictive pattern
(  FRC-FVC)
Lung collapse
* airway closure
* atelectasis
Postoperative pulmonary complications
Hypoxemia Pneumonia Local inflammatory response Ventilator induced lung injury
* Decreased DO2 * Macrophage dysfunction * Local hypoxia or hyperoxia * Cyclic tidal recruitment
* Systemic ischemia-
reperfusion injury
* Loss of surfactant * Local mechanical
   parenchymal stress
* Tidal overdistension
* Delirium * Bacterial growth * Biotrauma *Time-prolonged ventilation
* Wound infection * Bacterial translocation
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(73, 75-78).  A Cochrane review indicates that pre-operative smoking 
cessation, especially ≥ 4 weeks prior to surgery may significantly improve 
outcomes (79).  The reduction in perioperative complications ranges from 
20% to 34% (80-82).  Difficulties in smoking cessation include mainly 
unwillingness on the part of the patient, increased workload on the staff, and 
the incurred expenses surrounding support programmes required for patient 
success (73). 
 
Smoking is a univariate risk factor for respiratory failure, unanticipated 
intensive care admission, pneumonia, adverse airway events, and 
unanticipated airway and breathing interventions (83). 
 
Smoking is relevant to anaesthetists for several reasons.  First, smoking 
increases the level of carboxyhaemoglobin, which can reach up to 10% in 
heavier smokers (83).  The increased level of carboxyhaemoglobin not only 
decreases the total amount of oxygen that is available, but also shifts the 
oxyhaemoglobin dissociation curve leftwards, impeding the release of oxygen 
to the tissues (84) This is particularly relevant in patients with cardiovascular 
disease, or risk, because smoking also causes coronary vasoconstriction (85).  
This occurs via both direct and indirect sympathetic outflow (86). 
 
In addition to altered gas dynamics smoking also impairs mucociliary 
clearance (87, 88).  This is in addition to the impairment resulting from inhaled 
volatile agents.  Cigarette smoking also impairs the function of both alveolar 
macrophages and neutrophils (89, 90).  One can also expect goblet cell 
hyperplasia accompanied by increased mucous production, as well as airway 
hyperreactivity (87, 88). 
 
The above data clearly demonstrates the negative impact of cigarette 
smoking on perioperative morbidity and mortality, and the benefits of 
perioperative smoking cessation.  It seems therefore worthwhile to promote 
smoking cessation as part of a structured programme during pre-operative 
evaluations. 
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Analgesia 
  
Traditional approaches to post-operative analgesia involve opioids with or 
without NSAIDS.  Whilst this approach may be appropriate for some patients 
in some cases it has several serious limitations.  The larger doses of opioids 
that are often required to manage post-operative pain following major 
thoracic, abdominal, or orthopaedic surgery also tend to centrally depress 
respiratory function. (3) Depression of respiratory function then increases the 
odds of POPCs. (66) 
 
Alternatively post-operative pain may be managed via neuraxial blockade.  A 
meta-analysis published in 2000 examined 158 trials of neuraxial blockade 
and found an overall decrease in perioperative mortality of approximately one-
third when compared to general anaesthesia and traditional opioid 
management. (91) Specific to post-operative pulmonary complications the 
authors identified a decrease in the occurrence of pneumonia as well as a 
decrease in the rate of respiratory depression.  Deaths related to these two 
reasons dropped in a similar fashion.  Interestingly, most studies analysed 
documented the continued benefit of neuraxial blockade regardless of 
whether or not it was maintained after the surgery.  As far as overall mortality 
was concerned, there was little difference between neuraxial blockade alone 
or combined with general anaesthesia.  The authors attributed the better 
outcomes to ease of pain-free breathing, increased blood flow, altered 
coagulopathy, and a decrease in the “surgical stress response”.  Ease of early 
pain-free movement may also have played a role. 
 
COPD is identified as an independent risk factor for POPC, as these patients 
can be extremely sensitive to alterations in respiratory drive and function. (47) 
There is some data supporting the notion that COPD patients may be 
between 300% - 700% more likely to develop pulmonary complications in the 
post-operative environment. (92) A study conducted in the Netherlands using 
this high-risk population documented a decreased risk of pneumonia within 30 
post-operative days without evidence of a decrease in pulmonary function as 
a result of epidural anaesthesia. (93) Neither the pulmonary function nor the 
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pneumonia rates varied with disease severity.  As a secondary end point, they 
also demonstrated better pain control in the group with epidural anaesthesia 
versus the traditionally managed group.  Despite a clear decrease in the rates 
of pneumonia, this study failed to demonstrate a statistically significant 
decrease in the overall mortality rate.  This is consistent with a large 
population-based cohort study that identified a small but statistically significant 
decrease in 30-day mortality. (94) It is possible that smaller studies will miss 
this data point as the number-needed-to-treat in that study was 447.  More 
significantly, the study did confirm the safety of epidural anaesthesia in this 
setting and its efficacy both in preventing POPC and improving pain control. 
 
Though not without risk, neuraxial blockade appears both safe and efficacious 
when used for the prevention of POPCs and the management of pain.  
Though the current evidence does not support its routine use to decrease 
crude mortality, it may be appropriate to employ it in patients at high risk for 
post-operative pulmonary complications or difficult to manage pain. 
Post-Operative Respiratory Failure (PRF) 
 
Post-operative respiratory failure represents the most common post-operative 
pulmonary complication, at approximately 50%.  It shows an incidence of up 
to 3.4% in general surgical populations and carries a mortality rate of up to 
25%. (47, 95) PRF is defined as the impairment of pulmonary gas exchange 
and hypoxia with or without hypercapnoea, in the absence of cardiac failure 
and as a result of surgery or anaesthesia. (47) Using PaO2:FiO2 levels, post-
operative respiratory failure is classified as mild, moderate, or severe. 
 
Respiratory muscle dysfunction contributes heavily to PRF. (96) Muscular 
dysfunction arises from residual anaesthetic agents, opiate effects on the 
central respiratory centre, and splinting from either pain or trauma. (47) 
Additionally, residual neuromuscular block affects not only the muscles of 
respiration, but also the airway muscles.  This means that, not only are the 
diaphragm and thoracic muscles potentially unable to completely expand the 
thorax due to weakness, but also that the muscles of the airways remain 
dilated.  This predisposes to lower pressures and increased risk of airway 
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collapse and atelectasis. (97) An inability to fully expand the thorax or the 
predisposition to airway collapse can maintain or perpetuate atelectasis 
potentially leading to a lengthened post-operative course or further lung injury. 
Inspiratory Muscle Training 
 
As inspiratory muscle weakness can be seen within two hours of the initiation 
of mechanical ventilation and is almost always present to some degree within 
forty-eight hours, it has been thought that inspiratory muscle conditioning 
could reverse this process, increasing respiratory muscle strength and 
endurance, especially that of the diaphragm.  Inspiratory training is delivered 
using a variety of methods that increase the pressure against which patients 
must draw a breath.  Two common methods are increasing the trigger 
pressure on the ventilator, and the use of an external impedance device. (15) 
In both methods the resistance is increased incrementally for short intervals 
over several days until the patient is thought to be capable of weaning. 
 
Whilst this represents a logical intervention, data is contradictory.  A 2011 
review (15) concluded that although inspiratory muscle training was favoured, 
it did not statistically improve the duration of weaning in a significant manner.  
The same conclusion was reached for overall survival.  No difference was 
found when considering re-intubation rates.  This is in concordance with a 
randomised trialconducted more recently that demonstrated no significant 
shortening of the weaning period. (98) This study however is limited in that 
patients in both the control and intervention group received non-invasive 
ventilatory support following extubation.  The study also failed to publish re-
intubation rates. 
 
Conversely, several studies have successfully demonstrated the benefit of 
inspiratory muscle training when considering the duration and success of 
weaning. (99-101) These studies showed small yet significant differences in 
both duration and outcome. 
 
All studies however reported a significant increase in peak inspiratory 
pressure, suggesting a significant increase in muscle strength.  Peak 
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inspiratory pressure currently represents the only clinically useful method of 
measuring respiratory muscle strength.  No study found any association 
between inspiratory muscle training and worsened outcomes.  It is possible 
that the inconsistent outcomes are a reflection of the homogenous nature of 
ICU patients requiring mechanical ventilation.  It would therefore be plausible 
to consider that there may be a subset of patients who would benefit from 
inspiratory muscle training.  As no danger has been demonstrated, it seems 
reasonable to consider inspiratory muscle training in patients at risk of failure 
to wean, such as those with a high Tomin index.  Although ultrasound has 
been shown capable of estimating diaphragmatic mass, no study has 
combined this with inspiratory training.  This may also prove of benefit in the 
future, assuming a minimum required muscle mass could be determined. 
Sedative Reduction and Sedative Selection 
 
Sedation in mechanically ventilated patients is employed to improve 
patient:ventilator synchrony, reduce patient stress and anxiety, facilitate 
medical care, and to improve patient comfort.  Amelioration of this stress also 
has the possible effect of reducing endogenous catecholamine release and 
oxygen consumption.  Significant evidence exists, however, demonstrating 
that excessive and prolonged sedation promotes longer durations of 
mechanical ventilation, longer ICU stays and worsened outcomes, including 
long-term cognitive impairment. (102-106)  
 
A recent multi-centre trial showed that deep sedation in the first forty-eight 
hours is an independent risk factor for delayed extubation and increased 
mortality. (106) The study concluded that each Richmond Agitation Sedation 
Scale (RASS) finding in the deep range was associated with a delay in 
extubation of 12.3 hours, a 10% increase in in-hospital death, and an 8% 
increase in mortality at six months.  Additionally, this study found that the use 
of midazolam was associated with longer periods of mechanical ventilation. 
This supports another study associating the use of benzodiazepines with 
longer periods of ventilation. (107) The fact that this study addressed the first 
48 hours is important, as many studies do not.  One other study assessed the 
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outcomes of patients without sedation in the first 48 hours and found 
significant improvements. (108) 
 
The use of daily sedation interruption, commonly known as a “sedation 
vacation” offers the theoretical benefit of avoiding the accumulation of the 
sedative agents and their active or toxic metabolites, providing the opportunity 
of assessment of the requirement for continued sedation, and allowing the 
patient to participate in daily spontaneous breathing tests.  As prolonged 
ventilation and deep sedation are known to promote worse outcomes, this 
potentially leads to a reduction in the duration of ventilatory support, 
shortened ICU and hospital stay, and an improvement in long-term outcomes. 
(102, 109) 
 
Currently, the two most common methods for reduction in exposure to 
sedation are daily sedative interruption, and protocolised targeted light 
sedation.  Hughes et al (104) found that, when used alone, these strategies 
were equally effective in reducing exposure to sedatives and improving 
outcomes when compared to deeply sedated patients.  The authors further 
suggested that either the combination of the two, or the combination of daily 
interruption with an awake spontaneous breathing trial, might be of greater 
benefit.  A finding that supports this is that outcomes are unchanged when the 
total dose of sedative is not decreased, even in the presence of a sedation 
vacation or lightened sedation.  Girard (110) actually studied the combination 
of daily sedation vacations in combination with spontaneous breathing tests 
and found a significant decrease in ventilator time, ICU stay, hospital stay, 
and overall mortality. 
 
To date only one trial has attempted to combine both targeted light sedation 
with daily interruption.  Paradoxically, the study found that there was no 
difference in outcome and that the patients in the combined group required 
higher doses of sedatives. (105) Several potential problems exist within this 
study.  First, the sedation scores published in the article are more consistent 
with moderate sedation, not light.  Also, the compliance with the study 
protocol was only 72%.  Potentially this means that the authors were not 
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actually studying lightly sedated patients, and that the data rather reflects 
what is already known about more deeply sedated patients.  Interestingly, the 
authors did identify a sub-set of surgical/trauma patients that benefitted from 
daily withdrawal of sedation alone.  
 
A recent-meta analysis of five randomised trials covering 699 patients found 
that daily interruption of sedation alone was not associated with reduced 
ventilatory duration, nor earlier extubation times. (102) Likewise no decrease 
in the length of ICU or total hospital stay was found.  The analysis did 
however identify a reduction in the likelihood of requiring tracheostomy.  No 
difference was noted in the re-intubation rates.  Importantly, the study found 
no detrimental effect associated with the use of daily sedation withdrawal. 
 
Good evidence exists to show that over-sedation of patients results in longer 
ICU and hospital stays, longer ventilation times, and poorer long-term 
outcomes.  It has been shown that total dose reduction of sedatives and that 
the avoidance of benzodiazepines can improve outcomes.  Evidence 
becomes inconsistent however when examining wither daily withdrawal of 
sedation or targeted light sedation.  Potentially, the introduction of these two 
practices has simply made clinicians more cognizant of sedation levels and 
total sedative doses.  Alternatively the inconsistent finding of various studies 
may be the result of an as yet unidentified sub-set of patients that benefit (or 
suffer) from both or either of these two practices.  Regardless of the 
inconsistencies in the data the adoption of either of these methods of sedation 
reduction appears safe, and when compared to previous model of sedation is 
certainly of benefit. 
Early Immunomodulary Nutrition 
 
Early perioperative enteral nutrition with substances promoting 
immunomodulation is controversial and contradictory.  Endotoxinaemia is 
reported in several studies and is thought to occur following abdominal 
surgery  
via direct contamination of more often as a result bacterial translocation.  
Endotoxinaemia thought to act in a pro-inflammatory manner and is 
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associated with higher levels of markers of inflammation and poorer 
outcomes. (111) Theoretically, early enteral nutrition would increase 
splanchnic circulation and decrease bacterial translocation, preventing an 
inflammatory cascade.  TNF alpha is known to be responsive to 
endotoxaemia and is probably responsible for the adverse effects, including 
protein/fat redistribution, cachexia, chemotaxis and inflammatory recruitment, 
and promoting anaerobic metabolism. (111) Elevated levels of TNFa are 
associated with worse outcomes.  The most common constituents of 
immunonutrition are omega-3 fatty acids, RNA, glutamine, and arginine.  Both 
animal and in vitro studies have demonstrated their ability to modulate cell-
mediated immune function, acute phase proteins, insulin release, and the 
post-traumatic inflammatory cascade. (112, 113) Unfortunately, despite more 
than two decades of clinical trials, studies are often equivocal and reliable 
data is still lacking.   
 
One study examined early perioperative immunomodulatory nutrition 
compared to a traditional approach and concluded that there was an overall 
attenuation of the inflammatory response. (114) This conclusion was only 
reached after the authors discounted the increased cytokine levels found in 
the interventional group. No overall difference in immunoglobulin levels was 
reported, nor was a difference in overall mortality. 
 
An industry-funded trial in 2007 reported a statistically significant decrease in 
the levels of endotoxin, CRP and TNFa. (115) It did not report rates of clinical 
complications or outcome. 
 
By far the best study is a 2010 meta-analysis reviewing 21 randomised 
controlled trials including 2730 patients. (116) The study showed that 
perioperative infections decreased in those receiving specialised early 
nutrition, as did the total number of days in the hospital.  Overall mortality 
following surgery in the interventional group was unchanged.  They further 
concluded that the cost associated with the programme was probably less 
than the cost associated with treating the prevented infections. 
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Current data suggests that early enteral immunonutrition may decrease the 
rate of postoperative infection, as well as the number of in-hospital days.  One 
possible limitation is that many studies used predominantly cancer patients, a 
subset of patients known to be immunocompromised and prone to infection. 
Whether or not these results are transferable to the general surgical 
population remains to be seen.  No study reported statistically significant 
improvements in outcome or mortality.  As no study however reported worse 
outcomes it seems reasonable that perioperative immunonutrition could be 
offered to at-risk patients without fear of complication. 
Lung-Protective Strategies During General Anaesthesia and 
Mechanical Ventilation 
Low-Volume Ventilation 
 
In 2000 a landmark trial using lower tidal volumes than conventional 
ventilation protocols in ARDS patients changed the way in which ALI/ARDS 
patients are ventilated. (117) The trial randomised 861 patients to either a 
lower Vt group (6ml/kg or predicted body weight) or to a convention ventilation 
group (10ml/kg – 15 ml/kg predicted body weight).  This higher tidal volume 
time represented the average protocol for a patient with ALI/ARDS at the time, 
as the goal was often both to ensure not only a viable FiO2 but also to 
normalise PaCO2 and pH.   So successful was this trial that it was suspended 
prematurely, as it was no longer possible to ethically enrol patients to the 
control group.  This study went on to form the foundation of the low tidal 
volume ARDSnet protocol in use around the world today.  Overall the 
reduction in mortality in the ALI/ARDS population requiring mechanical 
ventilation was reduced 22 per cent.  The authors further demonstrated that at 
all times the peak airway pressure and mean airway pressure remained lower 
in the interventional group.  Moreover, the PaO2 was not statistically or 
clinically altered in the interventional group, despite a significant increase in 
PaCO2.  In spite of this permissive hypercapnoea the patients were found to 
have a lower IL-6 level at every point where the two groups were compared.  
They also spent fewer days undergoing mechanical ventilation and had more 
favourable FiO2:PaO2 ratios.  This data has been confirmed by several 
studies since and is now the standard of care in ALI/ARDS. (5) 
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While a complete discussion of ventilation in the ARDS patient is well outside 
the scope of this paper, it is important to understand the genesis of low tidal 
volume ventilation.  So great was the improvement in mortality stemming from 
these recommendations, that the concept of low volume ventilation was 
rapidly transferred to non-ALI/ARDS patients, often without good clinical 
evidence. (118) 
 
In 2010 a randomised controlled trial compared traditional ventilation (10ml/kg 
pbw) to low tidal volume ventilation (6ml/kg pbw) in mechanically ventilated 
patients without acute lung injury. (119) The study was designed with the 
primary end point of cytokine levels in bronchoalveolar lavage and plasma 
and a secondary end point of the development of ALI.  Similar to the 2000 
ARDSnet trial, the 2010 trial was suspended early after the second interim 
analysis showed significantly higher rate of conversion to ALI in the non-
intervention (traditional) group.  The authors showed that, even in the 
absence of diagnosable ALI, the lung injury scores (LIS) were higher in the 
traditional group.  Not only were the LIS lower in the interventional group, they 
decreased overall from baseline.  Baseline plasma and BAL cytokine levels 
were comparable in both groups.  In patients not developing ALI, the plasma 
IL-6 levels declined more rapidly in the interventional group.  Predictably, 
plasma IL-6 increased in all patients developing ALI regardless of the mode of 
ventilation.  No significant difference was found in oxygenation, PaO2, or 
PaO2:FiO2 ratio.  The authors calculate an odds ratio of 5.1 for developing ALI 
at a tidal volume of 10ml/kg, and an odds ratio of 1.3 for each ml/kg above 
6ml/kg.  Statistical analysis of this data showed traditional ventilation to be an 
independent risk factor for the development or ALI in mechanically ventilated 
patients.  This study may be somewhat underpowered as ARDSnet guidelines 
had already been adopted at the time of study, requiring a switch to the 
ARDSnet low tidal volume protocol if ALI was identified.  
 
A 2012 meta-analysis examined 20 studies investigating the use of low Vt in 
patients without ALI/ARDS. (118) It was found that not only was mortality 
lowered in the low Vt group, but so was the development of lung injury.  
Though they were unable to demonstrate a significant difference in either 
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number of ventilator days or number of ICU days, they did show that low Vt 
decreased the total number in-hospital days.  The analysis also points to 
significantly lower numbers when considering VAP, atelectasis, and plateau 
pressure.  The authors conclude that higher (previously traditional) tidal 
volumes promote VILI and that the use of low Vt is associated with better 
outcomes.  
 
A recently published translational review found that low Vt ventilation in 
patients with identifiable pulmonary insult resulted in both decreased airway 
pressures and strain. (120) The study was also able to identify several studied 
specific types of damage to the lungs associated with mechanical ventilation.  
It was found that in addition to lowering the incidence of ALI, the overall rates 
of inflammation, pulmonary oedema, and capillary leakage were all 
decreased.  In contrast to the above meta-analysis from 2012, this study 
found a shorter duration of ventilation was associated with low Vt.  Lower 
rates of ALI/ARDS, lower mortality, and lower rates of VAP and other 
pulmonary infections were in concordance with previous studies.  
 
Though the 2012 meta-analysis included studies examining surgical patients, 
a 2006 study is worth mentioning specifically.  This study concluded that the 
use of more traditional tidal volumes was associated with a significantly higher 
risk of post-operative pulmonary failure after only a few hours of ventilation.  
(121) Fifty per cent of the patients developing post-operative respiratory 
failure met the diagnostic criteria for ALI.  The authors calculated an odds 
ratio of 1.56 per ml/kg above 6ml/kg Vt.  The study also associated 
aggressive fluid management with post-operative respiratory failure. 
 
Low tidal volume ventilation is the current standard of care for ALI/ARDS 
patients requiring ventilator support.  In many institutions, this mode of care is 
extended to those without ALI/ARDS and the currently available data supports 
this.  No study reviewed during the writing of this paper demonstrated a 
negative outcome as a result of low Vt ventilation.  All studies demonstrated a 
decrease in the number of ALI cases associated with mechanical ventilation 
regardless of the clinical setting.  Surgical studies included in the meta-
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analysis showed a decrease in the rate of post-operative pulmonary failure.  
In all studies in which it was considered, the PaO2 was maintained with Low 
Vt, even in the face of permissive hypercapnoea, which had no statistically 
significant impact.  Considering the available data, it appears that low tidal 
volume ventilation should now reflect the standard of care in patients requiring 
mechanical ventilation. 
Positive End Expiratory Pressure (PEEP) 
 
As previously discussed, atelectasis occurs in the majority of intubated 
patients with or without prior lung injury.  Atelectrauma occurs through a 
variety of mechanisms when the alveoli are allowed to repeatedly inflate and 
collapse resulting in localised inflammation and the release of inflammatory 
mediators.  Such a scenario may subsequently promote systemic 
inflammation and increases the risk of VILI.  
 
Positive end expiratory pressure prevents the alveolar pressure from reaching 
zero (atmospheric pressure), and is used as an instrument of stabilisation, 
preventing recruitment/derecruitment. (1, 122) This is explained by the fact 
that alveolar derecruitment seems a function of lower plateau pressures rather 
than low Vt. (123) Halter et al. (122) used diverse ventilation strategies in 
animal models with alveolar dysfunction and established that higher levels of 
PEEP effectively prevented alveolar collapse even in the presence of low tidal 
volumes.  During evaluation they found that lower levels of PEEP were 
associated with an increase in neutrophil infiltration, intra-alveolar oedema, 
and septal thickening.  The same authors also maintain that they were able to 
maintain a constant number of open alveoli throughout the high PEEP 
protocol, whilst lower PEEP resulted in progressive atelectasis.  This was 
seen during the experiment as increasing mean airway pressures and was 
confirmed histologically afterwards.  In humans, the use of PEEP with low 
tidal volumes is associated with a decrease in the frequency of post-operative 
pulmonary complications. (124, 125) 
 
 
	   40	  
Figure 7 
 
 
 
The use of PEEP, especially higher levels of PEEP in the setting of lung 
injury, appears to have more impact in the prevention of VILI than the use of 
low tidal volume ventilation. (122) Predictably it appears that the effect of 
PEEP on mortality is not uniform.  A recent Cochrane review (125) failed to 
demonstrate a decrease in the overall mortality of patients after the use of 
PEEP despite an obvious decrease in the rate of post-operative pulmonary 
complications.  In contrast to this, another group of researchers concluded 
that PEEP brought about a 5% decrease in mortality in patients with poor 
paO2:FiO2 ratios. (126)  
 
Prior to employing PEEP, one must be aware that it does have potential 
haemodynamic consequences.  PEEP can, depending on cardiac function, 
either increase or decrease cardiac output through elevation of intrathoracic 
pressures. (41) An increase in intrathoracic pressure typically reduces venous 
Furthermore, mechanical ventilation can infl uence 
both local and systemic immune responses [1] because 
mechanical forces within the lungs trigger diﬀ erent 
biological responses that spread into the systemic circu-
lation. Although much knowledge about this issue has 
been generated in recent years, the specifi c contribution 
of ventilator settings to the infl ammatory response (that 
is, the biological activity brought about increasing volu-
trauma or atelectrauma) is unknown, and this complex 
response is likely to be infl uenced by patients’ baseline 
conditions.
Conclusions
Knowledge of the mechanisms involved in VILI is 
important to develop ventilatory strategies that could 
result in clinical benefi ts. Recent advances suggest that 
isolated mechanical forces (plateau pressure, PEEP) 
cannot adequately explain VILI; rather, the amount of 
damage depends on the simultaneous interaction of these 
forces and the previous status of the lung parenchyma. 
Ultimately, dynamic changes in alveolar structure could 
be responsible for lung injury. Th e translation of these 
concepts to the bedside requires complex physiological 
reasoning and directed research.
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Figure 2. Eff ects of recruitment in alveolar stability. Alveolar stability can be achieved by the equilibrium between end-inspiratory and end-
expiratory volumes. This stability allows defi nition of a hypothetical safe zone (blue area). Because strain can be viewed as the ratio between these 
volumes, this zone corresponds to normal or lower strain values. On the contrary, excessive end-inspiratory deformation in lungs with a low resting 
volume leads to alveolar instability (red area). The arrows represent how the tidal volume (Vt) and positive end-expiratory pressure (PEEP) modify 
the end-inspiratory/end-expiratory ratio. In recruitable lungs, PEEP induces an increase in end-expiratory lung volume that allows ventilation to 
stay in the safe zone, and strain decreases. In the absence of recruitment, however, both the Vt and PEEP lead to a predominant increase in end-
inspiratory volume, therefore increasing strain. FRC, functional residual capacity.
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Effects of recruitment in alveolar stability.  
Alveolar stability can be achieved by the equilibrium between end-inspiratory and end- expiratory volumes. 
This stability allows definition of a hypothetical safe zone (blue area). Because strain can be viewed as the 
ratio between these volumes, this zone corresponds to normal or lower strain values. On the contrary, 
excessive end-inspiratory deformation in lungs with a low resting volume leads to alveolar instability (red 
area). The arrows represent how the tidal volume (Vt) and positive end-expiratory pressure (PEEP) modify the 
end-inspiratory/end-expiratory ratio. In recruitable lungs, PEEP induces an increase in end-expiratory lung 
volume that allows ventilation to stay in the safe zone, and strain decreases. In the absence of recruitment, 
however, both the Vt and PEEP lead to a predominant increase in end- inspiratory volume, therefore 
increasing strain. FRC, functional residual capacity. 	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return and consequently right ventricular preload.  A second potential 
consequence of PEEP is the formation of micro ruptures or blebs, though this 
is usually only seen at high levels of PEEP. (5) Notwithstanding these two 
caveats, this author is unaware of any study concluding that appropriate 
levels of PEEP, even in routine use, contributes to poorer outcomes.  
Considering the potential benefits of decreased atelectasis, improved V:Q 
ratios, better oxygenation, and decreased rates of VAPthe routine use of 
PEEP seems appropriate.  More so in the absence of significant contradictory 
evidence.  Outside of routine patient care, there is excellent evidence to 
support its use in at-risk patients as well as those already presenting 
difficulties with ventilation. 
 
Figure 8 
 
 
 
Considering the potential benefits of decreased atelectasis, improved V:Q 
ratios, better oxygenation, and decreased rates of VAP in the absence of 
significant contradictory evidence its routine use of PEEP seems appropriate.  
Outside of routine patient care there is excellent evidence to support its use in 
at-risk patients, as well as those already presenting difficulties with ventilation. 
  
alveolar expansion in normal lungs. Whereas some zones 
undergo only minimal changes in each breath, other 
zones undergo deformations of up to 20% of their length. 
Th is fi nding could have important consequences for VILI 
in healthy lungs.
Failure of any of the above-mentioned mechanisms 
leads to alveolar instability, understood as an excessive 
tissue deformation during each breath. Although this 
may be a vague term, and in fact the thresholds of stress 
and strain that lead to tissue injury are unknown, we will 
use it as a concept beyond the classic opening and closing 
hypothesis. In this sense, alveolar instability refers not 
only to tidal changes in aeration, but also to those 
circumstances of excessive lung tissue deformation 
irrespective of the alveolar initial status. Th is common 
mechanism could help to override the diﬀ erent hypo the-
sis on lung injury induced by cyclic changes in lung 
aeration (that is, opening and closing of alveoli versus 
fl uid and foam in airways and alveoli [37]). Most 
circumstances that increase alveolar instability also 
increase the risk of VILI. Whereas the current paradigm 
considers alveolar insta bility and VILI to be concomitant 
consequences of an unknown cause, we hypothesize that 
alveolar instability is the main mechanism in VILI. Lung 
injury increases alveolar instability, and alveolar damage 
starts in the unstable zones [19]; VILI could spread from 
these zones where tidal changes are more relevant. Th ese 
zones are also present in healthy lungs, so this model 
could explain the induction of VILI in patients with and 
without previous lung injury.
Some studies have explored how ventilatory parameters 
infl uence lung deformation (Figure 1). Halter and colleagues 
demonstrated that changes in subpleural alveoli correlate 
directly to Vt and inversely to PEEP [38]. Interestingly, 
even with high Vt (up to 15 ml/kg), increasing PEEP 
levels from 5 to 20 cmH2O decreased alveolar instability 
from 108% to 15%. Experiments performed in cells 
corroborate these fi ndings. Using cell cultures submitted 
to cyclic stretch, Tschumperlin and colleagues showed 
that the magnitude of deformation was more important 
than the peak stretch in inducing cell death [39].
Excessive tissue deformation can also explain why 
healthy lungs ventilated with high Vt and moderate 
pressures develop lung injury. Vt promotes a time-
dependent increase in alveolar instability that could lead 
to lung damage [40]. Retrospective clinical studies have 
found that high Vt increases the risk of lung injury 
[28,29], and a recent randomized clinical trial found a 
higher risk of ARDS with 10 ml/kg Vt than with 6 ml/kg 
Vt [30].
Considering alveolar instability as the main mechanism 
of VILI explains how PEEP may reduce VILI [38]. Even 
during ventilation with high Vt, PEEP can signifi cantly 
reduce tidal changes in alveolar size. Valenza and 
colleagues found that VILI was delayed in intact rats 
ventilated with high airway pressures and PEEP [14]. One 
could hypothesize that PEEP avoids the progressive 
impairment in alveolar stability, as seen during in vivo 
microscopy studies.
Measurements of lung stability at the bedside
Explained in terms of stress and strain, ventilation with 
moderate/high PEEP and low Vt will reduce both stress 
(V ) and strain (higher EELV induced by higher PEEP), 
thus reducing the risk of superimposed ventilator-asso-
ciated lung injury. Terragni and colleagues found that 
even when Vt and plateau pressure are limited, patients 
with larger nonaerated lung compartments measured 
with computed tomography are exposed to tidal hyper-
infl ation, with excessive lung deformation of the aerated 
compartment at each tidal breath [41]. Similarly, in 
patients with focal ARDS ventilated with the ARDSnet 
protocol, using a physiologic approach to PEEP setting 
based on the shape of the airway pressure curve as a 
function of time during constant fl ow attenuated alveolar 
hyperinfl ation [42]. Lack of lung recruitment with PEEP 
during protective lung ventilation is again associated 
with excessive lung deformation.
Chiumello and colleagues found that the plateau 
pressure and Vt were inadequate surrogates for lung 
stress and strain due to considerable overlap at both 
diﬀ erent Vt and PEEP values, and strain was clearly over-
estimated when recruitment was computed [34]. Th ese 
results accounted for the high variability in functional 
Figure 1. Infl uence of ventilatory settings in alveolar stability. 
Diff erences between end-expiratory and end-inspiratory alveolar size 
increase with tidal volume and decrease with positive end-expiratory 
pressure (PEEP) (measured in an experimental model of lung injury). 
Note the synergistic relationship between these two parameters, 
and that PEEP may decrease the change in size in spite of high tidal 
volumes. Data extracted from [38].
Albaiceta and Blanch Critical Care 2011, 15:304 
http://ccforum.com/content/15/2/304
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Influence of ventilatory settings in alveolar stability. 
Differences between end-expiratory and end-inspiratory 
alveolar size increase with tidal volume and decrease with 
positive end-expiratory pressure (PEEP) (measured in an 
experimental model of lung injury). Note the synergistic 
relationship between these two parameters, and that PEEP 
may decrease the change in size in spite of high tidal 
volumes. 	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Recruitment Manoeuvres 
 
As discussed elsewhere in this paper, lung recruitment manoeuvres form part 
of the open-lung concept and are used in an attempt to ventilate atelectic 
areas of the lung so they become available for gas-exchange.  Generally, this 
involves temporary increases in peak inspiratory pressure, an increase in 
PEEP, inspiratory hold, or a combination of the above, with a subsequent 
return to open-lung ventilation. (3) 
 
As explained above, PEEP plays a central role in open lung ventilation.  
Unfortunately, little data exists on exactly how much PEEP should be 
employed in the clinical setting.  Using data available from experimental trials, 
most authors advocate a starting PEEP of 5cmH20.  This likely represents 
either an under- or over-pressure in many patients.  Compounding this 
problem is the fact that few, if any, authors explain what to do after “starting”.  
Recently explored is the concept of individualising PEEP, however this 
requires more information that is routinely attained at the bedside.  Optimal 
PEEP would be a post-recruitment PEEP level that prevents alveolar collapse 
while minimising overdistension and promoting maximal arterial oxygen 
tension and compliance with minimal dead space. (127) 
 
In order to accomplish this, it is necessary that one know that opening and 
closing pressures of the lungs, or the upper and lower inflection points.  
Evidence has shown that when the pressure in the lungs stays between these 
two points the amount of biotruama is reduced. (3) A recent study 
demonstrated that volumetric capnography and pulse oximetry after titration of 
Fi02 are able to serve as accurate real time indicators of opening and closing 
pressures for the purpose of PEEP individualisation. (128) The authors found 
a lower prevalence of atelectasis following recruitment in patients whose 
PEEP had been titrated versus those with standardised PEEP. 
 
In patients undergoing surgery, individualised PEEP was shown to 
significantly better lung mechanics, oxygenation, and atelectasis. (129) The 
study demonstrated that alveolar recruitment manoeuvres effectively 
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increased static compliance, but that this was only maintained using tailored 
PEEP.  This suggests that standardised PEEP may often be set too low to 
maintain an open lung and prevent recruitment/derecruitment injury.  These 
results are in concordance with Slinger et al who showed that the open lung 
benefits gained via recruitment were better maintained using titrated PEEP. 
(130) Likewise, in an animal model, Silva et al demonstrated that the stepwise 
application of recruitment manoeuvres produced similar results with less 
biotruama. (131) Alternatively, forced expiratory technique (FOT) has been 
shown to accurately determine lung tissue elastance.  Though requiring 
significantly more study Zinnan et al demonstrated that FOT could be used to 
guide ventilator settings in order to minimise recruitment/derecruitment in 
animals. (132) A direct measure of atelectasis, or derecruitment, is 
ultrasound.  Ultrasound has been successfully used to visualise derecruitment 
of alveoli during SBTs. (133) These same authors postulate that it could be 
used to guide ventilator and PEEP settings. 
 
A fairly well documented, but not often used, recruitment method is prone 
positioning.  Prone positioning is thought to be effective through several 
mechanisms including: an increase in end-expiratory lung volume, better 
ventilation perfusion matching via removal of lower lobe gravity dependence, 
lessening the mass-effect of the heart, and improving regional ventilation. (5) 
These effects combine to improve lung homogeneity.  One study showed that 
70% of hypoxic patients with ARDS had improved oxygenation once prone. 
(134) The PROSEVA trial established a sixteen per cent decrease in 
absolute, and a fifty per cent relative reduction in mortality in ARDS patients 
when positioned prone as compared to standard. (135) A recent review of two 
meta-analyses found that prone positioning was associated with improved 
oxygenation and survival in ALI/ARDS patients. (136) It went on to suggest 
that prone positioning in hypoxic non-ALI/ARDS patients may be of benefit.  It 
is important to note that prone positioning in the absence of PEEP only 
improves the ratio of aerated tissue to non-aerated tissue. (137) When 
combined with PEEP, however, it acts synergistically, significantly improving 
compliance and gas exchange while decreasing recruitment/derecruitment 
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injury.  This suggests that while prone positioning is an effective recruitment 
strategy, it requires recruitment maintenance in a manner similar to others. 
 
Good data exists demonstrating the usefulness of prone positioning as a 
recruitment manoeuvre in both animal models and ALI/ARDS patients.  
Similar evidence gained from clinical trials harkens improved outcomes when 
used in combination with PEEP.  Little data exists however outside of the 
ALI/ARDS setting, though a review did suggest that it may be useful.  It is 
important to note that no study demonstrated negative outcomes or 
complications associated with prone positioning.  As such prone positioning 
may be appropriate in the hypoxic, difficult to ventilate patient with or without 
ALI/ARDS.  Certainly this requires further study. 
 
Ventilator-Associated Pneumonia Bundles 
 
Table 1 shows the CDC recommended guidelines for the prevention of VAP.  
Several studies have attempted to validate or implement these 
recommendations – alone or in combination with other strategies – in real-
world ICUs with mixed success.   
 
Staff education regarding the pathogenesis, impact, and prevention of VAP is 
an important first step towards reduction of incidence. Salahuddin et al. (27) 
established a VAP education programme to reinforce the CDC guidelines and 
the rational behind them.  In doing so they reduced the incidence of VAP in 
the study ICU by 51%, reaching 6.5 ± 1.5 cases per 1000 ventilator-case 
days.  Jansson et al. (26) conducted a systematic review of 8 previous studies 
and found that on-going educational programmes directed towards the 
reinforcement of staff knowledge had a significant impact on VAP rates.  Most 
studies were able to demonstrate a reduction in VAP rates of approximately 
fifty per cent.  There was also an overall decrease in ICU stay and cost.  
Some, though not all, were further able to express an improvement in clinical 
outcomes. 
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As the most probable route of entry for causative pathogens is oropharyngeal 
microaspiration, the recommendation for regular oral care seems logical.  Not 
all studies have been able to demonstrate a clear benefit however, perhaps 
because oral care is multifactorial.  One conundrum is the decision to use 
antiseptic or antibiotic agents.  Antibiotics may be effective but could also 
promote increased antibiotic resistance; antiseptics act via multiple receptor 
sites theoretically reducing the risk of resistance. (138) A systematic review of 
sixteen trials (139) concluded that both antiseptic and non-iseganan topical 
antibiotics significantly reduced the risk of VAP.  Iseganan-containing 
antibiotics demonstrated a slight, but not statistically significant increase in 
VAP rates. Paradoxically, they were unable to demonstrate a significant 
reduction in all-cause mortality, duration of ventilation, or duration in the ICU 
even in the presence of reduced VAP numbers.  The study did not 
unfortunately exam the difference in VAP-associated mortality. 
 
Enteral support in critically ill patients plays several roles and is associated 
with better outcomes in critically ill patients. (140, 141) In this context, 
however, it can both increase and decrease the incidence of VAP, depending 
mostly upon the time of implementation. (142) In the critical care environment 
enteral nutrition typically results in a caloric and nitrogen deficit.  This deficit is 
often overcome using parenteral nutrition, however this does not improve 
clinical outcomes. (143, 144) One study (142) noted that patients receiving 
aggressive enteral nutritional support during the first week of ICU admission 
had higher rates of VAP than those receiving less aggressive enteral nutrition.  
The authors suggest that one, or a combination of nasogastric tubes, impaired 
gastric motility, inhibited lower oesophageal sphincter function may contribute 
to this phenomena.  In spite this, and in accordance with the studies 
examining VAP mortality above, they found no increase in death due to VAP, 
nor prolongation of ICU stays.  They did identify increased rates of 
septicaemia, VAP and death in patients receiving parenteral nutrition.  Finally, 
no negative outcomes were attributed to lower intake in the patients receiving 
fewer calories than indicated during the first week of admission.  This would 
seem to suggest that enteral nutrition, even at less than ideal levels required 
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to prevent the above identified complications, is superior to parenteral 
nutrition in terms of VAP rates and outcomes in general. 
 
Lastly, a three phase study examines the feasibility and efficacy of the CDC 
“VAP bundle” alone, combined with regular oral chlorhexadine 
decontamination, and then in combination with chlorhexadine and continuous 
aspiration of subglottic secretions (CASS). (145) The authors noted a 
significant increase in VAP rates when the CDC recommended VAP bundle 
was implemented alone.  Phase 2 added regular oral decontamination with 
chlorhexadine 0.12% to the VAP bundle and showed a decrease in VAP rates 
below the starting point.  The phase 2 VAP rate ranged from 1.3 – 2.0 case 
per 1000 ventilator-case days, a statistical rate of almost zero.  Not 
surprisingly then, the addition of CASS in phase three did not significantly 
affect the VAP rate.  CASS has been shown however to positively affect VAP 
rates in non-“zero VAP” departments (146) and may be beneficial in certain 
circumstances and institutions.  
 
VAP represents a significant mortality, resource, and cost burden in ICU 
patients.  Prevention is paramount and good evidence exists to supporting 
strategies to that end.  In addition to the CDC VAP bundle data supports 
ongoing staff education, oral decontamination with or without CASS, and early 
non-aggressive enteral nutritional support in the ICU. 
Conclusion 
 
Though mechanical ventilation only attained wide acceptance in the 1960s, it 
has rapidly become one of the most widely employed interventions in critical 
care units the world over.  It is now employed in the treatment of almost half of 
ICU patients.  Crucially, since its inception, it has undergone almost constant 
revision and research.  Mechanical ventilation is not in-and-of itself a 
treatment, rather it allows the patient to be maintained in a state that allows 
healing and treatment to take place.  By far the most common pathologies in 
which it is employed are sepsis, ALI/ARDS, trauma, and surgical patients.  
Additionally, it is often employed in specialty settings such as cardiac 
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intensive care units, and in the out-of-hospital environment.  The advent and 
development of mechanical respiratory support means that these patients can 
often remain stable enough to undergo treatment of the underlying pathology. 
 
Recently however a growing body of research shows that mechanical 
ventilation has the ability to cause pathologies as well.  In some cases, such 
as VILI/VALI, the produced disease is as bad, or worse, than the one being 
treated.  Additionally, mechanical ventilation’s required adjuvants, such as 
sedatives, analgesics, positioning, and alternative forms of nutrition all have 
the potential to contribute in some way to new or worsening disease. 
 
It should be clear that mechanical ventilation has many potential and diverse 
pitfalls, especially when considered in light of the fact that it is often the 
sickest and most complex patients who require it.  As such, it seems 
unreasonable to approach all ventilated patients in the same fashion, which 
until recently is essentially what clinical practice did.  Likewise, when one 
considers the complexity of mechanical ventilation and its complications it 
should be obvious that anything but multimodal prevention strategies are 
doomed to failure.  It is useless for instance to have a “zero-VAP” ICU, 
something that is possible, but experience high rates of lung injury because 
PEEP is not used properly. 
 
Unfortunately it is almost certain that no one multi-modal strategy will be 
effective, however.  What should be universal are risk-stratification and the 
anticipation of complications.  All patients should undergo thorough 
preoperative assessment, and should have their fluid balance carefully 
monitored.  All ventilated ICU patients should be subject to locally tailored 
VAP prevention bundles.  Low-volume ventilation and PEEP now both have 
enough evidence behind them that they should be considered standard 
practice.  In order for these to be truly effective, however, they require 
individual tailoring, something not currently done in most places.  Additionally, 
alternative interventions must be sought for the “difficult to ventilate” patient.  
This may be simply a repositioning of the patient, or a more in-depth re-
evaluation of the current treatment using alternative means. 
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Mechanical ventilation is a powerful tool, with both negative and positive 
effects.  It is clear that further research is required to clarify how a ventilator 
programme can be tailored to each individual patient. 
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